Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design-Reference-Cited by-同舟云学术

Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design

Published:2018-07-03 Issue:7 Volume:13 Page:e0199249
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Wada Hiroshi^ORCID,Shimizu Atsushi,Osada Toshihiro,Tanaka Yuki,Fukaya Satoshi,Sasaki Eiji

Funder

Taiho Pharmaceutical

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference51 articles.

1. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;SL Topalian;The New England journal of medicine,2012

2. Improved survival with ipilimumab in patients with metastatic melanoma;FS Hodi;The New England journal of medicine,2010

3. Peptide-based cancer therapy: opportunity and challenge;D Wu;Cancer letters,2014

4. Cancer immunotherapy: moving beyond current vaccines;SA Rosenberg;Nature medicine,2004

5. Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A;JN Cormier;The cancer journal from Scientific American,1997

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing the immunogenicity of Wilms tumor 1 epitope in mesothelioma cells with immunoproteasome inhibitors;PLOS ONE;2024-08-08

2. pepsickle rapidly and accurately predicts proteasomal cleavage sites for improved neoantigen identification;Bioinformatics;2021-09-03

3. Pepsickle rapidly and accurately predicts proteasomal cleavage sites for improved neoantigen identification;2021-05-17

4. TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice;Scientific Reports;2020-10-14

5. Correction: Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design;PLOS ONE;2018-10-04